Cargando…
Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India
BACKGROUND: People with Advanced HIV Disease (AHD) are at higher risk of TB coinfection and mortality. However, there are challenges in TB diagnosis with the currently recommended diagnostic tools. WHO recommends lateral flow urine lipoarabinomannan (LF-LAM) assay to assist TB diagnosis among AHD pa...
Autores principales: | Acharya, Shrikala, Deshpande, Prashant, Asirvatham, Edwin Sam, Palkar, Amol, Sarman, Charishma Jones, Laxmeshwar, Chinmay, Setia, Maninder Singh, Rathod, Dhirubhai, Koli, Sagar, Dale, Jayesh, Yeldandi, Vijay, Allam, Ramesh, Agarwal, Reshu, Verma, Sanjeev, Upadhyaya, Sunita, Nyendak, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473623/ https://www.ncbi.nlm.nih.gov/pubmed/36103506 http://dx.doi.org/10.1371/journal.pone.0273970 |
Ejemplares similares
-
Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India
por: Acharya, Shrikala, et al.
Publicado: (2023) -
Retrospective cohort analysis of survival of children living with HIV/AIDS in Mumbai, India
por: Acharya, Shrikala, et al.
Publicado: (2021) -
Factors associated with survival in adult people living with HIV/AIDS (PLHAs) in Mumbai, India (2004-2019): A retrospective cohort study
por: Acharya, Shrikala, et al.
Publicado: (2021) -
Barriers for Antiretroviral Therapy Adherence and Viral Suppression in Members of the Key Population in Mumbai, India: Implications for Interventions
por: Acharya, Shrikala, et al.
Publicado: (2021) -
Online partner seeking and high-risk behaviour in men who have sex with men and male-to-female transgendered people in Mumbai, India: Implications for prevention strategies
por: Acharya, Shrikala, et al.
Publicado: (2023)